The import of penicillins into France is forecasted to show a steady growth over the period from 2024 to 2028. The import value is expected to rise from $74.863 million in 2024 to $79.982 million in 2028, highlighting a consistent upward trend. This represents a compound annual growth rate (CAGR) of approximately 1.63%, reflecting a modest yet stable increase in imports year-on-year.

Future trends to watch for include:

Potential impacts of changes in international trade policies on pharmaceutical imports.
Advancements in antibiotic alternatives influencing penicillin demand.
Market responses to any outbreaks of bacterial diseases that might drive fluctuations in import volumes.